195 related articles for article (PubMed ID: 32279067)
1. Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway.
Zhao Z; Liu H; Li Y; Tian J; Deng S
Med Sci Monit; 2020 Apr; 26():e923025. PubMed ID: 32279067
[TBL] [Abstract][Full Text] [Related]
2. Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt/β-catenin signaling pathway.
Li Q; Jiang W; Wan Z; Ni Y; Lei L; Wei J
Life Sci; 2020 Jul; 252():117624. PubMed ID: 32259602
[TBL] [Abstract][Full Text] [Related]
3. A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy.
Jiang J; Lan C; Li L; Yang D; Xia X; Liao Q; Fu W; Chen X; An S; Wang WE; Zeng C
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3459-3467. PubMed ID: 30076960
[TBL] [Abstract][Full Text] [Related]
4. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
5. HECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt/β-Catenin Signaling Pathway.
Goto J; Otaki Y; Watanabe T; Kobayashi Y; Aono T; Watanabe K; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Arimoto T; Takahashi H; Shishido T; Watanabe M
Hypertension; 2020 Dec; 76(6):1868-1878. PubMed ID: 33131309
[TBL] [Abstract][Full Text] [Related]
6. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
7. Wnt-Signaling Inhibitor Wnt-C59 Suppresses the Cytokine Upregulation in Multiple Organs of Lipopolysaccharide-Induced Endotoxemic Mice via Reducing the Interaction between β-Catenin and NF-κB.
Jang J; Song J; Sim I; Kwon YV; Yoon Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200709
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II Increases HMGB1 Expression in the Myocardium Through AT1 and AT2 Receptors When Under Pressure Overload.
Zhang L; Zhang B; Yu Y; Wang J; Wu J; Su Y; Jiang H; Zou Y; Ge J
Int Heart J; 2021 Jan; 62(1):162-170. PubMed ID: 33455985
[TBL] [Abstract][Full Text] [Related]
9. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
[TBL] [Abstract][Full Text] [Related]
10. Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis.
Madan B; Patel MB; Zhang J; Bunte RM; Rudemiller NP; Griffiths R; Virshup DM; Crowley SD
Kidney Int; 2016 May; 89(5):1062-1074. PubMed ID: 27083283
[TBL] [Abstract][Full Text] [Related]
11. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.
Ma S; Feng J; Lin X; Liu J; Tang Y; Nie S; Gong J; Wang L
Oxid Med Cell Longev; 2021; 2021():5546867. PubMed ID: 34567409
[TBL] [Abstract][Full Text] [Related]
14. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
Zhai M; Liu Z; Zhang B; Jing L; Li B; Li K; Chen X; Zhang M; Yu B; Ren K; Yang Y; Yi W; Yang J; Liu J; Yi D; Liang H; Jin Z; Reiter RJ; Duan W; Yu S
J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28708271
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer.
Proffitt KD; Madan B; Ke Z; Pendharkar V; Ding L; Lee MA; Hannoush RN; Virshup DM
Cancer Res; 2013 Jan; 73(2):502-7. PubMed ID: 23188502
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide contributes to the attenuation of cardiac hypertrophy by suppressing endoplasmic reticulum stress.
Tian Q; Liu J; Chen Q; Zhang M
Pharm Biol; 2023 Dec; 61(1):61-68. PubMed ID: 36548192
[TBL] [Abstract][Full Text] [Related]
18. Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells.
Wang B; Zou Q; Sun M; Chen J; Wang T; Bai Y; Chen Z; Chen B; Zhou M
Oncol Rep; 2014 Nov; 32(5):2015-22. PubMed ID: 25224651
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.
Weng LQ; Zhang WB; Ye Y; Yin PP; Yuan J; Wang XX; Kang L; Jiang SS; You JY; Wu J; Gong H; Ge JB; Zou YZ
Acta Pharmacol Sin; 2014 Aug; 35(8):1005-14. PubMed ID: 24998254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
